Urinary Free THC Was Absent While Conjugated Cannabinoids Were Measurable
No free THC was detected in the controlled study’s urine specimens, yet conjugated cannabinoid measurements documented excretion. The negative parent-drug finding did not mean the administered cannabis had left no urinary evidence.
What the panel measured
Eleven frequent and nine occasional users completed controlled smoked, vaporized and oral cannabis sessions. Researchers analyzed 2,232 urine specimens for eleven cannabinoids and metabolites. THC, 11-hydroxy-THC, CBD, CBN, CBG, THCV and THCAA were not detected in the specimens. THC-COOH-glucuronide was the predominant measured analyte, and THC-glucuronide was also present.
Chemical form changes the question
A method measuring a free compound is not automatically measuring its conjugated forms. Hydrolysis can change that relationship, but this study directly distinguished free analytes and glucuronides. A report that compresses all of them into “THC in urine” loses an important part of the measurement definition. Nondetection also remains conditional on the method’s quantification limits.
How to interpret a negative result
Ask which compound and chemical form were sought before treating a negative finding as evidence of no cannabis exposure. Conversely, a measurable conjugate does not establish an exact dose, last-use time or degree of impairment. The study supplies controlled human excretion evidence; it does not make urine concentrations interchangeable with contemporaneous blood concentrations or observed performance.
Related analysis: the route-specific urine-model findings.
Research cited
Huestis and colleagues (2020). Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users. DOI: 10.1093/jat/bkaa046.
